42

2

Logo

LS CancerDiag

Company | Finland
1

followers

Primary tabs

About your organization

LS CancerDiag is committed to reducing cancer mortality rates with a diagnostic method that detects an inherited cancer-causing condition prior to cancer.

DiagMMR® is designed to be a predictive diagnostic tool that enables preventive follow-up and counselling for affected mutation carriers who are at high risk for developing Lynch syndrome related cancers. While current LS diagnosis relies on tumor studies, the quantitative DiagMMR® method allows carrier diagnosis based on a non-invasive tissue sample before the person has developed a cancer, without the knowledge and details of an inherited mutation.

News

Distribution agreements

Type of partnership
Offer
Scope of the partnership
Commercial

Kit co-development

Type of partnership
Ask
Scope of the partnership
Industrial

Licensing or partnerships for new markets.

Type of partnership
Offer
Scope of the partnership
Technological

Network (0)

There are no organizations in the network.

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.